Glenmark Takes Merck To Supreme Court Over Januvia Copies
This article was originally published in PharmAsia News
Executive Summary
In a fast-unfolding case, Glenmark has moved the Indian Supreme Court against Merck over copies of Januvia. The Indian drug maker had suffered a setback last week when the Delhi High Court restrained it from further producing and selling copies of the anti-diabetes brand.